|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.64 USD | +0.38% |
|
+1.43% | -27.86% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-26 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DAXOR CORPORATION | Closed End Funds | +0.38% | +1.43% | -27.86% | +12.00% | +3.80% | 61.77M |  | |  |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Charts Daxor Corporation
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
